About Taramed Overseas

Advancing animal health through science-driven pharmaceuticals and trusted partnerships worldwide.

Taramed Overseas was established by a team of experienced veterinarians and animal healthcare professionals with a singular vision: to advance animal health through innovative and reliable veterinary pharmaceuticals. With deep expertise and a commitment to excellence, we specialise in the development of high-quality, effective medications designed to meet the diverse needs of the veterinary sector.

Our portfolio includes preventive care and treatments for complex conditions — all developed under strict quality practices to ensure safety and consistency. We collaborate closely with veterinarians, distributors, and research partners to bring practical, clinically effective products to market.

Explore Products GMP-certified • Expert-backed formulations

Our Core

What drives our work — clearly and simply.

Vision

Advancing Global Veterinary Healthcare

Vision

To be a trusted partner to veterinarians worldwide by delivering consistent, innovative products.

Mission

Committed to Excellence in Veterinary Healthcare

Mission

At Taramed Overseas, our mission is to advance global veterinary healthcare by delivering scientifically proven, high-quality pharmaceutical solutions that address the diverse needs of animals. We are committed to ensuring that companion animals, livestock, and those requiring specialized care receive safe, effective, and reliable treatments.

Values

Integrity, Innovation, Compassion

Values

At Taramed Overseas, our values define who we are and guide every step we take. We uphold the highest standards of integrity and ethics, building trust and transparency with our partners.

Our Production Facility

State-of-the-art GMP-ready production environment.

Taramed Production

Our facilities follow international quality standards to ensure every batch meets strict safety and efficacy guidelines.

Taramed Market Presence

Market Presence — Gulf & Asia–Pacific

At Taramed Overseas, we command a growing presence across the Gulf and Asia–Pacific, positioning ourselves at the forefront of veterinary health solutions in these high-growth territories. In the Gulf, we are active in Saudi Arabia, the UAE, Qatar, and Oman—key markets where veterinary pharmaceuticals are experiencing strong momentum.

For example, Saudi Arabia dominates the Middle East animal health landscape with over half of the regional market share in 2024 and continues to expand rapidly. UAE is among the fastest-growing markets in the region, bolstered by robust government investments, a growing pet care culture, and initiatives aimed at food security and livestock health. Qatar is similarly on the rise, with rising pet ownership driving demand.

In Asia, we maintain a significant footprint in major markets like India, and Southeast Asia—regions defined by surging demand for veterinary medicines in both companion and livestock sectors.

Active markets include Saudi Arabia, UAE, Qatar, Oman, India, and Southeast Asia. If helpful, we can add country-level stats or an interactive map to this section.